Sensitivity and reproducibility of volume change measurements of different brain portions on magnetic resonance imaging in patients with multiple sclerosis
暂无分享,去创建一个
Marco Rovaris | Massimo Filippi | Giancarlo Comi | Matilde Inglese | Mariaemma Rodegher | M. Rovaris | M. Filippi | M. Sormani | G. Comi | R. V. van Schijndel | M. Inglese | M. Rodegher | Ronald A. van Schijndel | Maria Pia Sormani
[1] J K Udupa,et al. Glatiramer acetate (Copaxone) treatment in relapsing–remitting MS , 2000, Neurology.
[2] L D Blumhardt,et al. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis , 1999, Journal of neurology, neurosurgery, and psychiatry.
[3] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[4] I. Allen,et al. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis , 1979, Journal of the Neurological Sciences.
[5] Caterina Mainero,et al. Brain atrophy in relapsing-remitting multiple sclerosis: relationship with ‘black holes’, disease duration and clinical disability , 2000, Journal of the Neurological Sciences.
[6] M Rovaris,et al. Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis. , 1999, Current opinion in neurology.
[7] Massimo Filippi,et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis , 1995, Journal of the Neurological Sciences.
[8] A. Thompson,et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[9] W. Jagust,et al. Brain atrophy as a surrogate marker in MS , 2000, Neurology.
[10] P M Matthews,et al. Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging. , 1998, Brain : a journal of neurology.
[11] J M Bland,et al. Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .
[12] M. Rovaris,et al. Quantitative brain volumetric analysis from patients with multiple sclerosis: a follow-up study , 1999, Journal of the Neurological Sciences.
[13] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[14] J K Udupa,et al. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. , 1998, AJNR. American journal of neuroradiology.
[15] Massimo Filippi,et al. Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis , 1998, Journal of the Neurological Sciences.
[16] T. Hammeke,et al. Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and neuropsychological impairment. , 1985, Archives of neurology.
[17] L D Blumhardt,et al. Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. , 1999, Brain : a journal of neurology.
[18] L A Loizou,et al. Cranial computed tomography in the diagnosis of multiple sclerosis. , 1982, Journal of neurology, neurosurgery, and psychiatry.
[19] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[20] F. Barkhof,et al. Primary and transitional progressive MS , 1999, Neurology.
[21] P. Dastidar,et al. Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis , 1999, Journal of the Neurological Sciences.
[22] M Filippi,et al. The effect of imprecise repositioning on lesion volume measurements in patients with multiple sclerosis , 1997, Neurology.
[23] A. Thompson,et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. , 1995, Brain : a journal of neurology.
[24] J K Udupa,et al. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. , 2000, Radiology.
[25] C. Raine. Comparative neuropathology and immunopathology of multiple sclerosis and HTLV-1 myelopathy , 1992, Journal of Neuroimmunology.
[26] Lublin Fd,et al. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. , 1996 .
[27] A J Thompson,et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.
[28] R. Herndon,et al. A longitudinal study of brain atrophy in relapsing multiple sclerosis , 1999, Neurology.
[29] Ludwin Sk,et al. The neuropathology of multiple sclerosis. , 2000 .
[30] R. Rudick,et al. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS , 1999, Neurology.
[31] H. Adams,et al. Progressive cerebral atrophy in MS: A serial study using registered, volumetric MRI , 2000, Neurology.